DB14804InvestigationalSmall molecule
Iodine I-125 is under investigation in clinical trial NCT00079417 (Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma).
- Mechanism
- Curator reviewed
Pharmacologically active on Vascular cell adhesion protein 1
- Formula / weight
- I · 124.9046 g/mol (avg)
- Also known as
- 125-IODINE · Iodine-125 · Iodine125
Resolves to
Compound
Clinical / RWD
Structure
InChIKey
ZCYVEMRRCGMTRW-YPZZEJLDSA-NSMILES[125I]Targets
What you can answer from here — as of July 22, 2026
Which drugs share a target with Iodine I-125, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account